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Abstract
Background: The knowledge on population structure of the parasite isolates has contributed
greatly to understanding the dynamics of the disease transmission for designing and evaluating
malaria vaccines as well as for drug applications. msp-1 and msp-3α genes have been used as a
genetic marker in population studies of Plasmodium vivax isolates. In this study, msp-3α  was
compared and assessed with msp-1 marker in order to find whether msp-3α is a reliable genetic
marker for P. vivax population studies.
Methods: This comparative study was designed and carried out as the first assessment of diversity
in Pvmsp-3α gene by polymerase chain reaction-restriction fragment length polymorphism (PCR-
RFLP) in the 50 northern and 94 southern P. vivax isolates from Iran, which had been analysed
before for msp-1 gene.
Results: Three allele size as, Type A (1.8 kb), Type B (1.5 kb) and Type C (1.2 kb) have been
detected among both northern and southern isolates based on PCR results. Type C (70%) and Type
A (68.7%) were the predominant fragments among northern and southern parasites, respectively.
99 distinct Pvmsp-3α fragments defined by the size were detected in the 94 southern samples by
PCR analysis. However, no mixed genotype infections have been detected among northern isolates.
Based on restriction pattern from digestion with Hha I and Alu I 12 and 49 distinct allelic variants
have been detected among 50 northern and 94 southern isolates. However, based on msp-1 gene,
30 distinct variants identified in all 146-sequenced Iranian P. vivax isolate.
Conclusion: The results suggested that PCR-RFLP on msp-3α gene is an adequate, applicable and
easily used technique for molecular epidemiology studies of P. vivax isolates without the need for
further sequencing analysis.
Background
Knowledge of the population structure of the parasite iso-
lates is important to understand the dynamics of disease
transmission. Molecular epidemiological studies require
reliable polymorphic markers [1]. Four polymorphic
markers have been used to study the genetic structure of
Plasmodium vivax, including Pvgam1, which encodes for a
protein expressed during sexual stages [2,3]Pvcs, the cir-
cumsporozoite protein [4-6], Pvmsp-1  coding for the
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merozoite surface protein 1 [7-11] and Pvmsp-3α, encod-
ing for the merozoite surface proteins 3α [12-14].
A number of genes encoding for P. vivax MSPs have been
identified, including Pvmsp-1 [8], Pvmsp-3α, Pvmsp-3β and
Pvmsp-3γ [12,15], Pvmsp-4 and Pvmsp-5 [16] and Pvmsp-9
[17]. Of these, Pvmsp-1 has been most extensively studied
and the sequence of the Pvmsp-1 gene varies between iso-
lates from different part of the world. Pvmsp-3α, Pvmsp-3β
and  Pvmsp-3γ  are members of a multi-gene family of
related MSPs [8,15]. The three encoded proteins share
only 35–38% identity and 48–53% similarity in pair-wise
comparisons. They all contain similar structures including
signal sequences and are expressed on the merozoite sur-
face. The MSP-3α of P. vivax is a protein with a molecular
weight ranging from 148 to 150 KD, an alanine-rich cen-
tral domain and a series of heptad repeats that were pre-
dicted to form a coiled-coil tertiary peptide structure.
Pvmsp-3α, like Pvmsp-1, is very polymorphic and has been
used as a genetic marker in population studies of isolates
from diverse geographic localities and origins [13,14,18].
In Iran, malaria is endemic in southeastern regions,
including Hormozgan, Sistan and Baluchistan and the
tropical part of Kerman provinces. In addition, malaria re-
appeared in northern Iran in 1994 [19]. More than 80%
of reported malaria cases in the south are due to P. vivax
infection. Recent study on the 52 northern and 94 south-
ern P. vivax parasite isolates carried out to determine the
extent of genetic diversity and population structure of this
parasite by using block 5 region of Pvmsp-1 gene [20]. A
total of 7 and 27 distinct variants were detected among
northern and southern isolates, respectively. Sequence
alignments demonstrated the heterogeneity of P. vivax iso-
lates in Iran and also showed that the parasites from the
southern malaria endemic area were more polymorphic
than those circulating in the northern area.
In this study, msp-3α was compared and assessed with the
msp-1 marker in order to find out whether msp-3α is a reli-
able genetic marker for P. vivax population studies. There-
fore, the same set of sequenced sample was examined here
using the Pvmsp-3α gene by polymerase chain reaction-
restriction fragment length polymorphism (PCR-RFLP).
Materials and methods
Study area and sample collection
P. vivax isolates were collected from two different malaria
endemic areas as previously described [20]. This study was
approved by the Ethical Review Committee of Research in
Pasteur Institute of Iran. In this comparative study 50
northern and 94 southern isolates, which had been
already sequenced for variable block 5 of Pvmsp-1, were
selected for further analysis using Pvmsp-3α marker [20].
Extraction of DNA
P. vivax genomic DNA was extracted from 250 µl of
infected venous blood, using standard phenol/phenol-
chloroform methods, following washing of cells, saponin
lysis of red blood cells and digestion with proteinase K
[21]. The DNA sample was resuspended in 30–50 µl of
sterile TE buffer, and stored at -20°C until use.
Polymerase chain reaction amplification of the Pvmsp-3α 
gene
Allelic diversity of the msp-3α gene was studied using the
modified PCR-RFLP method described by Bruce and col-
leagues [13]. Briefly, the msp-3α gene was amplified by a
nested PCR, using 2 µl of DNA extract in first reaction and
0.1 µl of the primary reaction in the second amplification.
The oligonucleotide PCR primers were as described by
Bruce and co-workers [13]. One unit of Taq polymerase,
with 0.2 µM final concentration of both primers and 0.2
mM of each 4-deoxynucleotide triphosphates were used
in reaction buffer containing 1.5 mM MgCl2. The reaction
was carried out for 94°C for 3 min, 35 cycles at 94°C for
1 min, 56°C for 1 min, and 72°C for 2.5 min and a final
primer extension at 72°C for 10 min. However, in second
round reaction, 95°C for 2 min, 30 cycle at 94°C for 1
min, 62°C for 1 min, 72°C for 1.5 min and a final primer
extension at 72°C. Two µl of the second PCR product was
electrophoresed on a 1.5% agarose gel.
PCR-RFLP analysis of Pvmsp-3α gene
For RFLP analysis, both Hha I and Alu I were used for
digestion [13]. Approximately 10 µl of the PCR product
was digested individually with the both restriction
enzymes in total 20 µl reaction volumes as described by
manufacture (Roche Company). The DNA fragments were
visualized under UV illumination after electrophoresis on
2% agarose gels. Major alleles were classified based on the
differences in restriction banding patterns.
Results
PCR amplification of the Pvmsp-3α gene
Fifty northern and 94 P. vivax southern isolates were suc-
cessfully amplified for the msp-3α gene. A total of 99 dis-
tinct  Pvmsp-3α fragments defined by the size were
detected in the 94 southern samples by PCR analysis,
showing that some patients (five of 94) had infections of
more than one parasite genotype. No mixed genotype
infections have been detected among northern isolates.
Based on the length variants of the PCR products, three
allele sizes, Type A (1.8 kb), Type B (1.5 kb) and Type C
(1.2 kb) have been detected among both northern and
southern isolates (Figure 1). The predominant fragments
among northern and southern parasites were Type C
(70%) and Type A (68.7%)  respectively.  However, the
remaining of 24% (12 of 50) of northern isolates wasMalaria Journal 2006, 5:53 http://www.malariajournal.com/content/5/1/53
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Type A, and 6% (3 of 50) were Type B. In addition, 7% (7/
99) of southern samples were Type B, and 19% (18/99)
were Type C   (Figure 2).
PCR-RFLP analysis of Pvmsp-3α gene
Both Hha I and Alu I enzymes showed clear restriction pat-
terns in all analyzed samples. In all northern and southern
isolates the RFLP patterns showed 500–600 bp for Alu I
digests (Figure 3A) and the largest fragments between
950–1100 bp for Hha I (Figure 3B), as showed by others
[13,22,23]. These fragments were not included for distin-
guishing different alleles, as it was difficult to resolve,
however, smaller fragments from 150–750 bp were
applied for RFLP analysis in this study (Figure 3).
Based on restriction patterns from digestion of PCR prod-
ucts with Hha I and Alu I, 12 and 49 distinct variants have been detected among 50 northern and 94 southern iso-
lates.
As we have shown before, based on msp-1 analysis, 30 dis-
tinct variants identified in all 146-sequenced Iranian P.
vivax isolate. These variants were grouped in; Type 1 (B1–
B9), Type 2 (S1–S16) and Type 3 (R1–R5) [20]. However,
by using msp-3α gene, followed by RFLP analysis with Hha
I and Alu I enzymes, more variation between and within
different Type and sub Types of Iranian Pvmsp-1  were
detected. Based on Pvmap-3α, the most diverse group of
Pvmsp-1  was Type 2 S1 variants with 10 allelic forms
(Table 1). Furthermore, the number of different allelic
variants of Pvmsp-3α in Type 1 (B1–B9), Type 2 (S1–S16),
and Type 3 (R1–R5) of Pvmsp-1 has been shown in Table
1. The two samples belonging to Type 3 R2 were not
included in this analysis because there were no more
blood and DNA samples available at the time of this
study. The RFLP results showed high diversity among
PCR-RPLF patterns of Iranian P. vivax isolates based on  Pvmsp-3α Figure 3
PCR-RPLF patterns of Iranian P. vivax isolates based on 
Pvmsp-3α. The amplification products were digested by Alu I 
(A) and Hha I (B). The lane with the molecular weight 
marker (100 bp ladder) is labeled M.
Figure 1: Lane 1-5 and 6-9 are uncut msp-3α polymerase  chain reaction amplification products of some representative  samples of Iranian P. vivax isolates. Figure 1
Figure 1: Lane 1-5 and 6-9 are uncut msp-3α polymerase 
chain reaction amplification products of some representative 
samples of Iranian P. vivax isolates. The lane with the molecu-
lar weight marker (100 bp ladder) is labeled M (Roche)
Frequency distribution of allele sizes, Type A (1.8 bp), Type B  (1.5 bp) and Type C (1.2 bp) found in P. vivax isolates col- lected in the northern (n = 50) and southern isolates (n = 94)  endemic areas Figure 2
Frequency distribution of allele sizes, Type A (1.8 bp), Type B 
(1.5 bp) and Type C (1.2 bp) found in P. vivax isolates col-
lected in the northern (n = 50) and southern isolates (n = 94) 
endemic areas.Malaria Journal 2006, 5:53 http://www.malariajournal.com/content/5/1/53
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Table 1: PCR-RFLP analysis of msp-3α gene in 50 northern and 94 southern P. vivax clinical isolates from Iran. B = Belem Type 1; S = 
Salvador I Type 2; R = Recombinant Type 3 [20]. N = northern sample, S = southern sample. Different allelic variants obtained from 
sequencing analysis of Iranian Pvmsp-1 gene grouped to Type 1 (B1–B9), Type 2 (S1–S16) and Type 3 (R1–R5). Within the same Type 
all samples showed 100% similarity at both nucleotides and protein levels [20]. However, applying PCR-RFLP for genetic analysis of 
identical P. vivax samples by using Pvmsp-3α marker showed allelic variants within each Type.
Isolate Group Amplified fragment size Number of the allelic variant based on RFLP method
Type A (1800 bp) Type B (1500 bp) Type C (1200 bp) Hha I Alu I
B1N 3/37 (8.1%) 2/37(5.4%) 31/37(83.8%) 4 4
B1S - - 1/37 (2.7%) 1 1
B2N - - 2/2 (100) 1 1
B 2 S --- - -
B 3 N --- - -
B3S 3/3 (100%) - - 2 2
B 4 N --- - -
B4S 1/1 (100%) - - 1 1
B 5 N --- - -
B5S - 1/1 (100%) - 1 1
B 6 N --- - -
B6S 2/2 (100%) - - 1 1
B 7 N --- - -
B7S - - 2/2 (100%) 2 2
B 8 N --- - -
B8S 3/3 (100%) - - 1 1
B 9 N --- - -
B9S 3/3 (100%) - - 2 2
S1N 5/23 (21.7%) 1/23 (4.3%) - 3 3
S1S 13/23 (56.5%) 2/23 (8.7%) 2/23 (8.7%) 7 7
S2N 3/9 (34%) - 1/9 (11%) 2 2
S2S 1/9 (11%) 2/9 (22%) 2/9 (22%) 3 3
S3N - - 1/1 (100%) 1 1
S 3 S --- - -
S 4 N --- - -
S4S 1/1 (100%) - - 1 1
S 5 N --- - -
S5S 2/2 (100%) - - 1 1
S 6 N --- - -
S6S 1/1 (100%) - - 1 1
S 7 N --- - -
S7S 1/1 (100%) - - 1 1
S 8 N --- - -
S8S 2/2 (100%) - - 1 1
S 9 N --- - -
S9S 5/5 (100%) - - 1 1
S 1 0 N --- - -
S10S 3/3 (100%) - - 2 2
S 1 1 N --- - -
S11S 1/1 (100%) - - 1 1
S 1 2 N --- - -
S12S 2/9 (22.2%) 1/9 (11.1%) 6/9 (66.7%) 2 2
S 1 3 N --- - -
S13S 1/2 (50%) - 1/2 (50%) 2 2
S 1 4 N --- - -Malaria Journal 2006, 5:53 http://www.malariajournal.com/content/5/1/53
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southern isolates in comparispn to northern isolates that
was similar to the results obtained previously [20].
Discussion
The majority of researchers have used msp-1  gene as
molecular markers for structural analysis of wild P. vivax
isolates from different malaria endemic areas, which relies
almost entirely on sequencing. However, the Pvmsp-3α
gene has been recently applied and suggested as a poly-
morphic marker for molecular epidemiological studies
[13,14]. This survey has been carried out to evaluate the
Pvmsp-3α marker for molecular epidemiology studies of P.
vivax. Pvmsp-3α was applied to the same DNA samples of
P. vivax isolates from Iran that had been previously ana-
lysed with the Pvmsp-1 marker. The analysis of Pvmsp-1
gene in Iranian isolates had been carried out by sequenc-
ing analysis while the Pvmsp-3α gene was only analysed
using the PCR-RFLP method.
The PCR-RFLP analysis of the msp-3α gene demonstrated
that P. vivax parasites were highly diverse in Iran. Further-
more, the parasite population was more diverse among
southern isolates compared to northern isolates, which
was in concordance with the result of the Pvmsp-1
sequencing analysis. In addition, sequencing analysis of
the Pvmsp-1 gene showed 9 different allelic variant of Type
1 (B1–B9), 16 allelic variant of Type 2 (S1–S16) and 5
allelic variants of Type 3 (R1–R5) in 146 isolates. Within
the same type and allelic variant group, all samples
showed 100% similarity at both nucleotides and protein
levels [20]. However, in the present study using a Pvmsp-
3α  analysis of the same samples, the results showed
greater variation within each group. Therefore, these
results support that this genetic marker may be more use-
ful and sensitive than the msp-1 marker, without the need
for further sequencing analysis.
Furthermore, in the previous msp-1 study, [20] none of the
samples showed any multiple infections, while 5 of 144
isolates showed multiple infections by using the msp-3α
marker.
Conclusion
The results demonstrated that the Pvmsp-3α is a powerful
polymorphic marker, which could be applied for both
genotyping, identification of mixed genotype parasite
infections, and population structural analysis of P. vivax
isolates. It is of particular importance to note that the msp-
3α marker could be used with PCR-RFLP alone, without
the need for further sequencing.
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S14S 1/1 (100%) - - 1 1
S 1 5 N --- - -
S15S 2/2 (100%) - - 2 2
S 1 6 N --- - -
S16S 1/1 (100%) - - 1 1
R1N 1/3 (33.4%) - - 1 1
R1S 2/3 (66.6%) - - 2 2
R 2 N --- - -
R 2 S --- - -
R 3 N --- - -
R3S 2/4 (50%) 1/4 (25%) 1/4 (25%) 3 3
R 4 N --- - -
R4S 2/2 (100%) - - 2 2
R 5 N --- - -
R5S 13/17 (76.5%) - 4/17 (23.5%) 4 4
Total (144) 80 (55.5%) 10 (7%) 54 (37.5%) 61 61
Table 1: PCR-RFLP analysis of msp-3α gene in 50 northern and 94 southern P. vivax clinical isolates from Iran. B = Belem Type 1; S = 
Salvador I Type 2; R = Recombinant Type 3 [20]. N = northern sample, S = southern sample. Different allelic variants obtained from 
sequencing analysis of Iranian Pvmsp-1 gene grouped to Type 1 (B1–B9), Type 2 (S1–S16) and Type 3 (R1–R5). Within the same Type 
all samples showed 100% similarity at both nucleotides and protein levels [20]. However, applying PCR-RFLP for genetic analysis of 
identical P. vivax samples by using Pvmsp-3α marker showed allelic variants within each Type. (Continued)Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Malaria Journal 2006, 5:53 http://www.malariajournal.com/content/5/1/53
Page 6 of 6
(page number not for citation purposes)
Acknowledgements
This study was financially supported by Institut Pasteur of Iran.
References
1. Read A, Day KP: The genetic structure of malaria parasite pop-
ulations.  Parasitol Today 1992, 8:239-242.
2 . S n e w i n  V A ,  K h o u r i  E ,  W a t t a v i d a n a g e  J ,  P e r e r a  L ,  P r e m a w a n s a  S ,
Mendis KN, David PH: A new polymorphic marker for PCR typ-
ing of Plasmodium vivax parasites.  Mol Biochem Parasitol 1995,
71:135-138.
3. Snewin VA, Premawansa S, Udagama PV, Mattei DM, Khouri E, Del
Giudice G, Mendis KN, David PH: Transmission blocking immu-
nity in Plasmodium vivax malaria: Antibodies raised against a
peptide block parasite development in the mosquito vector.
J Exp Med 1995, 181:357-362.
4. Arnot DE, Stewart MJ, Barnwell JW: Antigenic diversity in Thai
Plasmodium vivax circumsporozoite proteins.  Mol Biochem Par-
asitol 1990, 43:147-150.
5. Mann VH, Huang T, Cheng Q, Saul AJ: Sequence variation in the
circumsporozoite protein gene of Plasmodium vivax appears
to be regionally biased.  Mol Biochem Parasitol 1994, 68:45-52.
6. Qari SH, Collins WE, Lobel HO, Taylor F, Lal AA: A study of Poly-
morphism in the circumsporozoite protein of human
malaria parasites.  Am J Trop Med Hyg 1994, 50:45-51.
7. Cheng Q, Stowers A, Huang TY, Bustos D, Huang YM, Rzepczyk C,
Saul A: Polymorphism in Plasmodium vivax MSA-1 gene: The
result of intragenic recombinations?  Parasitology 1993,
106:335-345.
8. Del Portillo HA, Longacre S, Khouri E, David PH: Primary struc-
ture of the merozoite surface antigen 1 of Plasmodium vivax
reveals sequences conserved between different Plasmodium
species.  Proc Natl Acad Sci USA 1991, 88:4030-4034.
9. Pasay MCJ, Cheng Q, Rzepczyk CM, Saul AJ: Dimorphism of the C
terminus of the Plasmodium vivax merozoite surface protein
1.  Mol Biochem Parasitol 1995, 70:217-219.
10. Premawansa S, Snewin VA, Khouri E, Mendis KN, David PH: Plasmo-
dium vivax: recombination between potential allelic types of
the merozoite surface protein MSP-1 in parasites isolated
from patients.  Exp Parasitol 1993, 76:192-199.
11. Putaporntip C, Jongwutiwes S, Tanabe K, Thaithong S: Interallelic
recombination in the merozoite surface protein (MSP-1)
gene of Plasmodium vivax from Thai isolates.  Mol Biochem Par-
asitol 1997, 84:49-56.
12. Galinski MR, Corredor-Medina C, Povoa M, Crosby J, Ingravallo P,
Barnwell JW: Plasmodium vivax merozoite surface protein-3
contains coiled-coil motifs in an alanine-rich central domain.
Mol Biochem Parasitol 1999, 101:131-147.
13. Bruce MC, Galinski MR, Barnwell JW, Snounou G, Day KP: Polymor-
phism at the merozoite surface protein-3α locus of Plasmo-
dium vivax.  Am J Trop Med Hyg 1999, 61:518-525.
14. Bruce MC, Galinski MR, Barnwell JW, Donnelly CA, Walmsley M,
Alpers MP, Walliker D, Day KP: Genetic diversity and dynamics
of Plasmodium falciparum and Plasmodium vivax populations
in multiply infected children with asymptomatic malaria
infections in Papua New Guinea.  Parasitology 2000, 121:275-272.
15. Galinski MR, Ingravallo P, Corredor-Medina C, Al-Khedery B, Povoa
M, Barnwell JW: Plasmodium vivax merozoite surface proteins-
3β and 3γ share structural similarities with P. vivax mero-
zoite surface protein-3α and define a new gene family.  Mol
Biochem Parasitol 2001, 115:41-53.
16. Black CG, Barnwell JW, Huber CS, Galinski MR, Coppel RL: The
Plasmodium vivax homologues of merozoite surface proteins
4 and 5 from Plasmodium falciparum are expressed at differ-
ent locations in the merozoite.  Mol Biochem Parasitol 2002,
120:215-224.
17. Vargas-Serrato E, Barnwell JW, Ingravallo P, Perler FB, Galinski MR:
Merozoite surface protein-9 of Plasmodium vivax and related
simian malaria parasites is orthologous to p101/ABRA of P.
falciparum.  Mol Biochem Parasitol 2002, 120:41-52.
18. Mueller I, Kaiok J, Reeder JC, Cortes A: The population structure
of Plasmodium falciparum and Plasmodium vivax during an epi-
demic of malaria in the Eastern Highlands of Papua New
Guinea.  Am J Trop Med Hyg 2002, 67(5):459-464.
19. Zakeri s, Mamaghani S, Mehrizi AA, Shahsavari Z, Raeisi A, Arshi S,
Djadid ND: Molecular evidence of mixed P. vivax and P. falci-
parum infections in northern Islamic Republic of Iran.  East
Med Health J 2004, 10:336-342.
20. Zakeri S, Mehrizi AA, Mamaghani S, Noorizadeh S, Snounou G, Djadid
ND:  Population structure analysis of Plasmodium vivax in
areas of Iran with different malaria endemicity.  Am J Trop Med
Hyg 2006, 74:394-400.
21. Snounou G, Viriyakosol S, Zhu XP, Jarra W, Pinheiro L, do Rosario
WE, Thaithong S, Brown KN: High sensitivity of detection of
human malaria parasites by use of nested polymerase chain
reaction.  Mol Biochem Parasitol 1993, 61:315-320.
22. Rayner JC, Corredor V, Feldman D, Ingravallo P, Iderabdullah F,
Galinski MR, Barnwell JW: Extensive polymorphism in the Plas-
modium vivax merozoite surface coat protein MSP-3α is lim-
ited to specific domains.  Parasitology 2002, 125:393-405.
23. Cui L, Mascorro CN, Fan Q, Rzomp KA, Khuntirat B, Zhou G, Chen
H, Yan G, Sattabongkot J: Genetic diversity and multiple infec-
tions of Plasmodium vivax malaria in western Thailand.  Am J
Trop Med Hyg 2003, 68:613-619.